top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
Precision Medicine : Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
Autore Turgeon Jacques
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (170 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato fibromyalgia (FM)
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
microRNA
miRNome
pharmacogenomics
pharmacoepigenomics
SM2miR
Pharmaco-miR
repoDB
ME/CFS Common Data Elements (CDEs)
dihydropyrimidine dehydrogenase
DPYD
5-fluorouracil
fluoropyrimidine
therapeutic drug monitoring
orthotopic liver transplant
busulfan
glutathione S-transferase
genetic polymorphism
limited sampling strategy
pharmacokinetics
clinical pharmacogenetics
pharmacogenetic testing
adverse drug reactions
genotype
phenotype
pharmacogene
barriers to pharmacogenetics implementation
Sub-Saharan Africa
chronic low back pain (cLBP)
genetics
personalized treatment
polymorphism
CYP450
tacrolimus
CYP3A5
liver transplant
pharmacogenomic
minority
data collection
drug
biomarker
pharmacogenetics
pharmacogenetic test
personalized medicine
gene expression
infliximab
adalimumab
ulcerative colitis
Crohn disease
inflammatory bowel disease
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Precision Medicine
Record Nr. UNINA-9910585940803321
Turgeon Jacques  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Research of Pathogenesis and Novel Therapeutics in Arthritis / Chih-Hsin Tang
Research of Pathogenesis and Novel Therapeutics in Arthritis / Chih-Hsin Tang
Autore Tang Chih-Hsin
Pubbl/distr/stampa Basel, Switzerland : , : MDPI, , 2019
Descrizione fisica 1 electronic resource (366 p.)
Soggetto non controllato receptor activator of nuclear factor ?B
infliximab
tripterine
triptolide
osteoblast
tumor necrosis factor-alpha
synovial cell
anti-arthritis
biosimilars
Epstein-Barr virus
cytokines
SOX9
parathyroid hormone
nitric oxide
rat
etanercept
angiogenesis
glycosylation
mitogen activated protein kinase
Th9 lymphocytes
rheumatoid arthritis
IL-6
clodronate
bone erosion
mesenchymal stem cells
collagen-induced arthritis
biological
gene expression
inflammatory arthritis
osteoarthritis
fraxinellone
nuclear factor kappa B
messenger RNA
inflammation
miRNA
disease-modifying
adipokines
WNT
glycoprotein 42
miR-199a-5p
proliferation
next-generation sequencing
collagen
osteoarthritis (OA)
experimental arthritis
bone morphogenetic protein
TNF-?
computational modeling
basic research
osteoclast
therapeutics
certolizumab pegol
chondrocytes
progenitor cells
adjuvant arthritis
adalimumab
triterpenoid
sclareol
TNF?
fibroblast growth factor 2
antibodies
osteoblasts
molecular pathology
Th17
immunology
obesity
visfatin
articular cartilage
autoimmune
biomarkers
celastrol
MAPK
disease pathways
IL1?
arthritis
bioinformatics
anticitrullinated peptide antibodies
drug delivery system
antagonists
shared epitope
pathology
SMA- and MAD-related protein
small-molecule inhibitor
transforming growth factor ?
mice
golimumab
spinal fusion
antirheumatic drug
early osteoarthritis
stem cell
rheumatoid factor
therapeutic antibody
bisphosphonate
osteoclastogenesis
interleukin
spondyloarthropathies
clinical translation
therapy
Traditional Chinese medicine
chemokines
structure
cell signaling
microRNA
ISBN 9783038970668
3038970662
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346843303321
Tang Chih-Hsin  
Basel, Switzerland : , : MDPI, , 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Autore Müller Rüdiger
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (260 p.)
Soggetto topico Medicine
Soggetto non controllato rheumatoid arthritis
sleep
sleep disorders
pain
osteoporosis
fracture
fracture risk assessment tool
treat-to-target
certolizumab pegol
csDMARDs
glucocorticoids
intra-articular injections
DAS 28
ACR response
HAQ-DI
TNFα
golimumab
efficacy
tolerability
immunogenicity
methotrexate
posology
titration
oral route
subcutaneous route
bioavailability
effectiveness
periodontitis
periodontal disease
anti-citrullinated protein autoantibodies
rheumatoid factor
smoking
medication
Porphyromonas gingivalis
Rheumatoid arthritis
matrix metalloproteinase 3
infliximab
pharmacogenomics
anti-TNF
personalized medicine
baricitinib
disease-modifying antirheumatic drugs
pain perception
outcomes research
patient perspective
Rheumatoid Arthritis
therapy
DMARD
MTX
Tumor Necrosis Factor-Alpha Inhibitors
ankylosing spondylitis
biosimilar
switching
synovial fibroblasts
cytokine
osteoclast
herbal medicine
methylation
next-generation sequencing
recovery of function
fatigue
productivity
tofacitinib
oral
Th1.17
IL-17A
IFN-γ, CD73
adenosine
psoriatic arthritis
regulation
pseudoerosions
hand
foot
ultrasonography
radiography
computed tomography
magnetic resonance imaging
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Rheumatoid Arthritis Therapy Reappraisal
Record Nr. UNINA-9910557286503321
Müller Rüdiger  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui